Find and Pitch Jounalists, Get Your Story Covered

Tags: electric vehicles EV EVs Polestar Polestar 2

	Profile	Recent Articles on Subject
1	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Corbus reports first Western data for closely tracked ADC cancer drug - 10 days ago
2	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	New Bispecific Shrinks NRG1 Fusion-Positive Lung, Pancreatic Tumors - 18 days ago Another Win for Antibody-Drug Conjugate in HER2+ Breast Cancer With Brain Mets - 5 months ago Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies - 7 months ago A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu - 12 months ago Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results - 12 months ago Atezolizumab Plus Carboplatin Boosts Survival in Metastatic TNBC - about 1 year ago Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug - about 1 year ago Tucatinib Regimen Boosts PFS in Advanced HER2-Positive Breast Cancer - about 1 year ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - over 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - over 1 year ago Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancer - over 1 year ago
3	Wayne Kuznar MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Using Immune Biomarkers to Guide Treatment in TNBC - about 2 months ago Study Supports ADC as a New Option for Endocrine-Resistant Metastatic Breast Cancer - about 1 year ago Novel Therapies Show Early Promise in Advanced Gastroesophageal Cancers - over 1 year ago
4	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Can Tumor Mutational Burden Guide Treatment in Metastatic Breast Cancer? - about 2 months ago Dato-DXd More Effective, Tolerable Than Chemo for Metastatic Breast Cancer - about 1 year ago Adding Tucatinib to T-DM1 Shows PFS Benefit in HER2-Positive Breast Cancer - about 1 year ago 'Exploding' Field of Antibody-Drug Conjugates Makes Inroads in Ovarian Cancer - about 1 year ago T-DXd Could Be 'Practice-Changing' in HER2-Expressing Gynecologic Cancers - about 1 year ago Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer - about 1 year ago Anti-TIGIT Drug Fails to Lift Response Rates in Cervical Cancer Trial - over 1 year ago The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer - over 1 year ago What's New in Targeted Lung Cancer Treatment? - over 1 year ago
5	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	SABCS 2024: Using Tumor Immune Profiles to Guide Neoadjuvant Therapy in Young Breast Cancer Patients - 2 months ago Antibody Drug Conjugate Targeting CLDN1 Receives FDA Fast Track Designation - 3 months ago FDA Grants Breakthrough Therapy Designation to DS-8201a and T-DXd to Treat Metastatic Breast Cancer - 6 months ago
6	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 4 months ago Immunotherapy and Chemotherapy Combinations Show Promise for High-Risk HR+/HER2– Breast Cancer - 4 months ago Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 5 months ago Advancements in HER2+ Breast Cancer Treatment: Insights From the HER2CLIMB-02 Trial - about 1 year ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Expert Discusses Immunotherapy, Antibody Drug Conjugates for Lung Cancer - 5 months ago
8	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: A new drug offers a rare option for brain cancer treatment — and inspires hopes for more - 5 months ago
9	Crystal Phend MedPage Today Contributing editor at MedPage Today. Personal views. HealthcareEditing	The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer - 8 months ago
10	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Another ADC Developer Lands a Mega Round of Financing for Cancer Clinical Trials - 11 months ago

Journalists covering breast cancer,breast cancer brain metastases ,recurrent glioblastoma multiforme ,antibody drug conjugates ,Trop-2